PERMA-Based Mobile Psychological Intervention With and Without Telephone Support for University Students

March 6, 2026 updated by: Vanessa Blanco Seoane, University of Santiago de Compostela

Efficacy of a Positive Psychology-Based Psychological Intervention Grounded in the PERMA Model Delivered Via Smartphone App, With and Without Telephone Multiconference Support, for the Promotion of Psychological Well-Being in University Students

University students face increasing academic and psychosocial demands that place them at risk of reduced psychological well-being. Positive psychology interventions have demonstrated efficacy in promoting mental health; however, few are grounded explicitly in Seligman's PERMA model and adherence to digital interventions remains limited. This randomized controlled trial aims to evaluate the efficacy of a brief PERMA-based psychological intervention delivered via a smartphone application, with and without supplementary telephone multiconference support, compared to a waiting list control group. The intervention consists of five weekly modules targeting Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment. Assessments will be conducted at baseline, post-intervention, and at six-month follow-up.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
177

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being an actively enrolled university student at the University of Santiago de Compostela (USC)
  • Having access to a smartphone with an internet connection.

Exclusion Criteria:

  • Having a current diagnosis of severe psychiatric disorder, including major depressive disorder with psychotic features, bipolar disorder, schizophrenia, severe cognitive impairment, dissociative disorders, or active substance dependence
  • Having started psychological or psychopharmacological treatment within the two months prior to the study or participating in another mental health-related study
  • Having insufficient proficiency in Spanish, or presenting sensory, cognitive, or physical impairments that would prevent engagement with the intervention
  • Planning to move out of Galicia within the next 12 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: App-based PERMA intervention (PPIA)
Behavioral intervention delivered via smartphone app. Five weekly modules corresponding to the PERMA domains.
Behavioral: App Based PERMA intervention
The PPIA intervention is a structured psychological program grounded in the PERMA model of well-being (Seligman, 2011). This model proposes that long-term flourishing depends on developing five pillars: Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment. The intervention is further supported by the broaden-and-build theory of positive emotions (Fredrickson, 2001), flow theory (Csikszentmihalyi, 1990), research on character strengths and positive relationships (Peterson & Seligman, 2004; Reis & Gable, 2003), meaning in life (Steger, 2009), the goal-setting theory (Locke & Latham, 2002) and growth mindset principles (Dweck, 2006).
Experimental: App-based PERMA intervention plus telephone multiconference (PPIA+M)
Same app-based intervention supplemented by weekly 30-minute group telephone multiconference sessions.
Behavioral: App Based PERMA intervention plus telephone multiconference
The PPIA intervention is a structured psychological program grounded in the PERMA model of well-being (Seligman, 2011). This model proposes that long-term flourishing depends on developing five pillars: Positive Emotion, Engagement, Relationships, Meaning, and Accomplishment. The intervention is further supported by the broaden-and-build theory of positive emotions (Fredrickson, 2001), flow theory (Csikszentmihalyi,1990), research on character strengths and positive relationships (Peterson & Seligman, 2004; Reis & Gable, 2003), meaning in life (Steger, 2009), the goalsetting theory (Locke & Latham, 2002) and growth mindset principles (Dweck, 2006). Additionally, the multiconference component will consist of weekly 30-minute telephone-based multiconference sessions. During these sessions, positive or corrective feedback will be delivered in accordance with Miltenberger's guidelines (Miltenberger, 2012) after reviewing the completed homework.
No Intervention: Waiting List Control Group (WLCG)
Participants receive no intervention during the study period and are granted access after completion.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change from baseline emotional well-being to post-intervention (5 weeks) and 6-month follow-up
Time Frame: Pre- and post -intervention (5 weeks) and 6-month follow-up
One of the primary outcomes of the study will be emotional well-being. This construct will be evaluated using the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS; Tennant et al., 2007).
Pre- and post -intervention (5 weeks) and 6-month follow-up
Change from baseline well-being to post-intervention (5 weeks) and 6-month follow-up
Time Frame: Pre- and post -intervention (5 weeks) and 6-month follow-up.
One of the primary outcomes of this study will be well-being (which comprises three elements, emotional, psychological and social well-being)l. This constructs will be evaluated using the Mental Health Continuum-Short Form (MHC-SF; Keyes, 2002).
Pre- and post -intervention (5 weeks) and 6-month follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Santiago de Compostela

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 31, 2029

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2029

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 27, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 6, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 12, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 12, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 6, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • USC-003/2026-H

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Researchers will report study results through publications. The data supporting these findings will be presented in the main publications, and the datasets used during the study can be obtained from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings